Browsing by Author Larrayoz, I.M. (Ignacio M.)
Showing results 1 to 8 of 8
| Issue Date | Title | Type | Author(s) |
| 2018 | Adrenomedullin, a novel target for neurodegenerative diseases | Articulo | Ferrero-Hidalgo, H. (Hilda) ; Larrayoz, I.M. (Ignacio M.); Gil-Bea, F.J. (Francisco J.); Martinez, J.A. (José Alfredo); Ramirez, M.J. (María Javier) |
| 2006 | Characterization of the rat Na+/nucleoside cotransporter 2 and transport of nucleoside-derived drugs using electrophysiological methods. | Articulo | Larrayoz, I.M. (Ignacio M.); Fernandez-Nistal, A. (Alonso); Gallego-Herrera, F. (Fernando); Gorraiz, E. (Edurne); Lostao, M.P. (María Pilar) |
| 2004 | Electrophysiological characterization of the human Na(+)/nucleoside cotransporter 1 (hCNT1) and role of adenosine on hCNT1 function. | Articulo | Larrayoz, I.M. (Ignacio M.); Casado, F.J. (F. Javier); Pastor-Anglada, M. (Marçal); Lostao, M.P. (María Pilar) |
| 2018 | Increased levels of brain adrenomedullin in the neuropathology of Alzheimer's Disease | Articulo | Ferrero-Hidalgo, H. (Hilda); Larrayoz, I.M. (Ignacio M.); Martisova, E. (Eva); Solas, M. (Maite); Howlett, D.R. (David R.); Francis, P.T. (Paul T.); Gil-Bea, F.J. (Francisco J.); Martinez, J.A. (José Alfredo); Ramirez, M.J. (María Javier) |
| 2004 | Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1) | Articulo | Cano-Soldado, P. (Pedro); Larrayoz, I.M. (Ignacio M.); Molina-Arcas, M. (Miriam); Casado, F.J. (F. Javier); Martinez-Picado, J. (Javier); Lostao, M.P. (María Pilar); Pastor-Anglada, M. (Marçal) |
| 2018 | Reduced adrenomedullin parallels microtubule dismantlement in frontotemporal lobar degeneration | Articulo | Ferrero-Hidalgo, H. (Hilda); Larrayoz, I.M. (Ignacio M.); Solas, M. (Maite); Martinez, J.A. (José Alfredo); Ramirez, M.J. (María Javier); Gil-Bea, F.J. (Francisco J.) |
| 2001 | Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[Prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug. | Articulo | Mata, J.F. (Joao F.); Garcia-Manteiga, J.M. (José M.); Lostao, M.P. (María Pilar); Fernandez-Veledo, S. (Sonia); Guillen-Gomez, E. (Elena); Larrayoz, I.M. (Ignacio M.); LLoberas, J. (Jorge); Casado, F.J. (F. Javier); Pastor-Anglada, M. (Marçal) |
| 2017 | β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells | Articulo | Peláez-Cristóbal, R. (Rafael); Morales-Urteaga, X. (Xabier); Salvo, E. (Elizabeth); Garasa, S. (Saray); Ortiz-de-Solorzano, C. (Carlos); Martinez, A. (Alfredo); Larrayoz, I.M. (Ignacio M.); Rouzaut, A. (Ana) |
